Research progress of a new oncotherapy target TRAP1
10.3969/j.issn.1001-1978.2016.04.004
- VernacularTitle:肿瘤治疗新靶点TRAP1研究进展
- Author:
Peiliang SHEN
;
Zhaoguo LIU
;
Lihua SUN
;
Xu WANG
;
Ying SHEN
;
Hongyan WU
;
Aiyun WANG
;
Yin LU
- Publication Type:Journal Article
- Keywords:
TRAP1;
AMPK;
tumor;
abnormal expression;
mo-lecular mechanisms;
clinical treatment
- From:
Chinese Pharmacological Bulletin
2016;32(4):459-462,463
- CountryChina
- Language:Chinese
-
Abstract:
Tumor necrosis factor receptor-associated protein 1 (TRAP1),as one of the main members of the heat shock protein 90 family, resists oxidative stress-induced apoptosis as well as predominantly maintains the integrity of mitochondria and cellu-lar homeostasis. Abnormal expression of TRAP1 was herein closely related to the onset and progression of a wide variety of tumors. As a key regulatory factor mediating energy metabolism within tumor cells, TRAP1 may be able to kill them by interfer-ing with such metabolism. More importantly, the abnormal ex-pression of TRAP1 played a less important role in normal cells, allowing TRAP1 to be a particularly attractive target as it can be used in tumor treatment or interference. The relationship be-tween abnormal expression of TRAP1 protein and tumor onset was reviewed. Besides, the mechanism by which disordered TRAP1 protein expression induced tumor formation was postula-ted, which may provide references for future research and clini-cal treatment.